Jaguar Animal Health (NASDAQ:JAGX – Get Free Report) and Cronos Group (NASDAQ:CRON – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk.
Analyst Recommendations
This is a summary of current ratings and price targets for Jaguar Animal Health and Cronos Group, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Jaguar Animal Health | 1 | 0 | 1 | 0 | 2.00 |
| Cronos Group | 1 | 2 | 2 | 0 | 2.20 |
Jaguar Animal Health presently has a consensus target price of $2,100.00, indicating a potential upside of 62,963.06%. Cronos Group has a consensus target price of $2.30, indicating a potential downside of 15.75%. Given Jaguar Animal Health’s higher probable upside, analysts plainly believe Jaguar Animal Health is more favorable than Cronos Group.
Earnings & Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Jaguar Animal Health | $11.51 million | 0.11 | -$53.43 million | ($1,162.24) | 0.00 |
| Cronos Group | $146.59 million | 7.01 | -$9.45 million | ($0.01) | -273.00 |
Cronos Group has higher revenue and earnings than Jaguar Animal Health. Cronos Group is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
12.0% of Jaguar Animal Health shares are owned by institutional investors. Comparatively, 8.7% of Cronos Group shares are owned by institutional investors. 2.1% of Jaguar Animal Health shares are owned by company insiders. Comparatively, 7.8% of Cronos Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Profitability
This table compares Jaguar Animal Health and Cronos Group’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Jaguar Animal Health | -464.20% | -1,194.94% | -114.26% |
| Cronos Group | -1.14% | -1.26% | -1.20% |
Risk & Volatility
Jaguar Animal Health has a beta of 0.01, indicating that its stock price is 99% less volatile than the S&P 500. Comparatively, Cronos Group has a beta of 0.87, indicating that its stock price is 13% less volatile than the S&P 500.
Summary
Cronos Group beats Jaguar Animal Health on 12 of the 14 factors compared between the two stocks.
About Jaguar Animal Health
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products. The company's products include Mytesi, an anti-secretory antidiarrheal drug for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy; and Canalevia-CA1, a prescription drug product for chemotherapy-induced diarrhea in dogs. It is also developing Crofelemer, an anti-secretory antidiarrheal drug, which is in Phase 3 clinical trial for or prophylaxis of diarrhea in adult cancer patients, and to address rare/orphan disease indications, including short bowel syndrome with intestinal failure and/or congenital diarrheal disorders; diarrhea-predominant irritable bowel syndrome; and for idiopathic/functional diarrhea. In addition, the company is developing NP-300, a second-generation antidiarrheal drug for symptomatic relief and treatment of moderate-to-severe diarrhea. The company is headquartered in San Francisco, California.
About Cronos Group
Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
Receive News & Ratings for Jaguar Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.
